Aster DM Healthcare Limited
ASTERDM
Rank in Stocks
#4194
Aster DM Healthcare Ltd. operates as an international healthcare provider with... Aster DM Healthcare Ltd. operates as an international healthcare provider with a significant presence in India and other global regions. The company's operations are segmented across hospitals, clinics, retail pharmacies, and other diversified services. It delivers a comprehensive range of medical care, from fundamental primary care to highly specialized quaternary services, supported by a vast infrastructure. This network includes 29 hospitals, 120 clinics, 371 retail pharmacies, 114 laboratories, and numerous patient experience centers, all operating under well-known brands such as Aster, Medcare, and Access. Beyond direct patient care, the company also provides healthcare retailing, diagnostic testing, digital health solutions, and medical education. Established in 1987, Aster DM Healthcare maintains its corporate headquarters in Dubai, United Arab Emirates.
Share Price
$7.36
Last synced: 2026-10-19
Market Cap
$3.81B
Change (1 day)
-1.19%
Change (1 year)
-9.92%
Country
IN
Trade Aster DM Healthcare Limited (ASTERDM)
Category
Healthcare
P/E ratio for Aster DM Healthcare Limited (ASTERDM)
P/E ratio as of October 2026 TTM: 112.02
According to Aster DM Healthcare Limited latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is 112.02. At the end of 2024 the company had a P/E ratio of 165.85.
P/E ratio history for Aster DM Healthcare Limited from 2011 to 2026
P/E ratio at the end of each year
| Year | P/E Ratio | Change |
|---|---|---|
| 2026 (TTM) | 112.02 | 43.65% |
| 2025 | 77.98 | -52.99% |
| 2024 | 165.85 | 488.75% |
| 2023 | 28.17 | 50.93% |
| 2022 | 18.67 | -59.62% |
| 2021 | 46.23 | 167.66% |
| 2020 | 17.27 | -25.62% |
| 2019 | 23.22 | -20.07% |
| 2018 | 29.05 | -31.33% |
| 2017 | 42.31 | -129.35% |
| 2016 | -144.17 | -324.84% |
| 2015 | 64.12 | 67.05% |
| 2014 | 38.38 | -48.41% |
| 2013 | 74.41 | -42.76% |
| 2012 | 129.99 | -106.36% |
| 2011 | -2.04K | 0.00% |
P/E ratio for similar companies or competitors
| Company | P/E Ratio | P/E Ratio Difference | Country |
|---|---|---|---|
| 15.70 | -85.98% |
US
|
|
| - | - |
DE
|
|
| 10.40 | -90.72% |
US
|
|
| 32.07 | -71.37% |
SA
|
|
| 20.00 | -82.15% |
BR
|
How to read a P/E ratio?
The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share.
A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.
Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.
Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.